Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The progression of chronic myelogenous leukemia (CML) to blast crisis is supported by self-renewing leukemic stem cells. In normal mouse hematopoietic stem cells, the process of self-renewal involves the beta-catenin-signaling pathway. We investigated whether leukemic stem cells in CML also use the beta-catenin pathway for self-renewal. METHODS: We used fluorescence-activated cell sorting to isolate hematopoietic stem cells, common myeloid progenitors, granulocyte-macrophage progenitors, and megakaryocyte-erythroid progenitors from marrow during several phases of CML and from normal marrow. BCR-ABL, beta-catenin, and LEF-1 transcripts were compared by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay in normal and CML hematopoietic stem cells and granulocyte-macrophage progenitors. Confocal fluorescence microscopy and a lymphoid enhancer factor/T-cell factor reporter assay were used to detect nuclear beta-catenin in these cells. In vitro replating assays were used to identify self-renewing cells as candidate leukemic stem cells, and the dependence of self-renewal on beta-catenin activation was tested by lentiviral transduction of hematopoietic progenitors with axin, an inhibitor of the beta-catenin pathway. RESULTS: The granulocyte-macrophage progenitor pool from patients with CML in blast crisis and imatinib-resistant CML was expanded, expressed BCR-ABL, and had elevated levels of nuclear beta-catenin as compared with the levels in progenitors from normal marrow. Unlike normal granulocyte-macrophage progenitors, CML granulocyte-macrophage progenitors formed self-renewing, replatable myeloid colonies, and in vitro self-renewal capacity was reduced by enforced expression of axin. CONCLUSIONS: Activation of beta-catenin in CML granulocyte-macrophage progenitors appears to enhance the self-renewal activity and leukemic potential of these cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both myelodysplastic syndrome (Pang et al., 2013) and acute and chronic myelogenous leukemias begin with nonlethal mutations in the HSC pool, often leading to successful expansion of mutant HSC clones at the expense of normal HSC, and which progress eventually to leukemia (Corces-Zimmerman et al., 2014; Jamieson et al., 2004; Jan et al., 2012)”
From Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle (2014) · cites this paper as Jamieson et al., 2004
In the citing paper
“Although CML is considered a HSC-initiated disease, studies indicate that granulocyte-monocyte progenitors isolated from advanced-phase CML patients reacquire self-renewal properties and therefore may also serve as LSC.6”
From Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo (2010) · cites this paper as [6]
In the citing paper
“Although CML is considered a HSC-initiated disease, studies indicate that granulocyte-monocyte progenitors isolated from advanced-phase CML patients reacquire self-renewal properties and therefore may also serve as LSC.6”
From Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo (2010) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Self-citationConstitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Self-citationA minute chromosome in human chronic granulocytic leukemia
Nowell̀, P. C. (1960) · Science · Cited by 2,269
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
Self-citationA role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Self-citation
Cited by
Items 201–300 of 1,000
Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer
Ge, Y., & Fuchs, E. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2018.9 · Cited by 168
The role of microRNAs in the regulation of cancer stem cells
Takahashi, R.-U., Miyazaki, H., & Ochiya, T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2013.00295 · Cited by 118
“Jamieson et al. showed that aberrations in the Wnt/β-catenin pathway enhance self-renewal activity during leukemia stem cell propagation (Jamieson et al., 2004).”
Backgroundp53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal
Zhao, Z., Zuber, J., Diaz-Flores, E., Lintault, L., Kogan, S. C., Shannon, K., & Lowe, S. W. (2010) · Genes & Development · doi:10.1101/gad.1940710 · Cited by 166
“How this occurs has been a topic of much debate, although fusion proteins involving the mixedlineage leukemia (MLL) gene and lesions enhancing Wnt/ b-catenin signaling can confer this capability (Cozzio et al. 2003; Jamieson et al. 2004; Krivtsov et al. 2006).”
BackgroundAntigens for cancer immunotherapy
Neller, M. A., López, J. A., & Schmidt, C. W. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.09.006 · Cited by 167
“[79] Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, et al.”
BackgroundClonal evolution in hematological malignancies and therapeutic implications
Landau, D. A., Carter, S. L., Getz, G., & Wu, C. J. (2014) · Leukemia · doi:10.1038/leu.2013.248 · Cited by 164
MicroRNA Regulation of Cancer Stem Cells and Therapeutic Implications
DeSano, J. T., & Xu, L. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9147-7 · Cited by 163
“Another study showed that, in chronic myelogenous leukemia, βcatenin accumulates in the nuclei of granulocyte–macrophage progenitors, seemingly enhancing the self-renewal activity and leukemic potential of these cells (53).”
BackgroundThe Cancer Stem Cell Hypothesis: Failures and Pitfalls
Rahman, M., Deleyrolle, L., Vedam-Mai, V., Azari, H., Abd-El-Barr, M., & Reynolds, B. A. (2011) · Neurosurgery · doi:10.1227/neu.0b013e3181ff9eb5 · Cited by 162
“Chronic myelogenous leukemia will eventually result in ‘‘blast crisis’’ in which proliferation and self-renewal take place in one cell that drives tumor growth and cannot be controlled indefinitely.(124) This phenomenon cannot be explained by a model in which the original CSCs self-renew and repopulate proliferating t…”
BackgroundDetection and analysis of mammary gland stem cells
Stingl, J. (2009) · The Journal of Pathology · doi:10.1002/path.2457 · Cited by 161
“Studies in the haematopoietic field have demonstrated that haematopoietic stem cells (HSCs) are the likely target for oncogenic mutation in human acute myeloid leukaemia (AML), since both the normal HSCs and the AML-CSCs share the same CD34+CD38− phenotype [79].”
BackgroundCancer Stem Cells: Controversial or Just Misunderstood?
Jordan, C. T. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.02.003 · Cited by 162
“Indeed, recent studies aimed at inhibition of known self-renewal pathways such as Wnt and Hedgehog have shown promising results (Jamieson et al., 2004; Peacock et al., 2007) and appear likely to warrant clinical testing.”
BackgroundNagaya, T., Friedman, J., Maruoka, Y., Ogata, F., Okuyama, S., Clavijo, P. E., Choyke, P. L., Allen, C., & Kobayashi, H. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0546 · Cited by 161
Gang, E. J., Hsieh, Y.-T., Pham, J., Zhao, Y., Nguyen, C., Huantes, S., Park, E., Naing, K., Klemm, L., Swaminathan, S., et al. (2014) · Oncogene · doi:10.1038/onc.2013.169 · Cited by 160
“Initially, we examined nuclear β- and γ-catenin levels in 13 primary (pre-B) ALL cases encompassing various cytogenetic aberrations (BCR/ABL1, TEL-AML1, E2A-PBX1, MLL-AF4, and normal karyotype) and two pre-B ALL cell lines BV173 (BCR/ABL-1) and 380 (t(8;14), t(14;18)).”
BackgroundBcr-Abl-mediated redox regulation of the PI3K/AKT pathway
Naughton, R., Quiney, C., Turner, S. D., & Cotter, T. G. (2009) · Leukemia · doi:10.1038/leu.2009.49 · Cited by 158
Yi, F., Sun, J., Lim, G. E., Fantus, I. G., Brubaker, P. L., & Jin, T. (2008) · Endocrinology · doi:10.1210/en.2007-1142 · Cited by 157
“The mouse monoclonal anti-GSK-3 (clone 4G-1E), and mouse anti- -catenin ( -cat, nonphosphorylated, clone 8E4) antibodies were from Upstate Biotechnology (Lake Placid, NY) (42).”
BackgroundCD99 is a therapeutic target on disease stem cells in myeloid malignancies
Chung, S. S., Eng, W. S., Hu, W., Khalaj, M., Garrett-Bakelman, F. E., Tavakkoli, M., Levine, R. L., Carroll, M., Klimek, V. M., Melnick, A. M., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaj2025 · Cited by 155
Rutella, S., Bonanno, G., Procoli, A., Mariotti, A., Corallo, M., Prisco, M. G., Eramo, A., Napoletano, C., Gallo, D., Perillo, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1883 · Cited by 160
Dietary and Metabolic Control of Stem Cell Function in Physiology and Cancer
Mihaylova, M. M., Sabatini, D. M., & Yilmaz, Ö. H. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.02.008 · Cited by 154
Stem Cell Research: Paths to Cancer Therapies and Regenerative Medicine
Weissman, I. (2005) · JAMA · doi:10.1001/jama.294.11.1359 · Cited by 152
Role of stem cells in cancer therapy and cancer stem cells: a review
Sagar, J., Chaib, B., Sales, K. M., Winslet, M. C., & Seifalian, A. M. (2007) · Cancer Cell International · doi:10.1186/1475-2867-7-9 · Cited by 165
Ettenberg, S. A., Charlat, O., Daley, M. P., Liu, S., Vincent, K. J., Stuart, D. D., Schuller, A. G., Yuan, J., Ospina, B., Green, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007428107 · Cited by 150
“In addition, Wnt signaling plays a critical role in the homeostatic regulation of tissue stem cells and hence, is implicated in the maintenance of cancer stem cells (17, 18).”
BackgroundABL Oncogenes and Phosphoinositide 3-Kinase: Mechanism of Activation and Downstream Effectors
Kharas, M. G., & Fruman, D. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3888 · Cited by 185
“The h-catenin pathway is activated and important in the self-renewal of granulocyte-macrophage progenitor cells that may provide the source for the Ph leukemia cells (74).”
BackgroundCancer stem cells and oncology therapeutics
Al-Hajj, M. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328011a8d6 · Cited by 148
Sengupta, A., Banerjee, D., Chandra, S., Banerji, S., Ghosh, R., Roy, R., & Banerjee, S. (2007) · Leukemia · doi:10.1038/sj.leu.2404657 · Cited by 165
Nakanishi, T., Shiozawa, K., Hassel, B. A., & Ross, D. D. (2006) · Blood · doi:10.1182/blood-2005-10-4020 · Cited by 148
“CML is regarded to be a clonal proliferative disease, with selfrenewing populations of stem and progenitor cells.(30,31) In normal HSC, BCRP is functionally expressed in a cell cycle quiescent, self-renewing population characterized by its ability to efflux Hoechst 33342 dye.”
BackgroundLim, S., Saw, T. Y., Zhang, M., Janes, M. R., Nacro, K., Hill, J., Lim, A. Q., Chang, C.-T., Fruman, D. A., Rizzieri, D. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301838110 · Cited by 154
“Importantly, the BC LSC population is also thought to underlie TKI resistance, as well act as a reservoir for the maintenance of the disease in patients (4, 6).”
BackgroundMethodResultInfluentialPTEN, Stem Cells, and Cancer Stem Cells
Hill, R., & Wu, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800071200 · Cited by 145
Leukemia stem cells in a genetically defined murine model of blast-crisis CML.
Neering, S. J., Bushnell, T., Sozer, S., Ashton, J., Rossi, R. M., Wang, P.-Y., Bell, D. R., Heinrich, D., Bottaro, A., & Jordan, C. T. (2007) · Blood · doi:10.1182/blood-2007-02-073031 · Cited by 129
“These data indicate that a feature of blast crisis disease may be significantly elevated levels of selfrenewal/growth within various progenitor populations, a finding consistent with similar studies from human CML.(33)”
ResultKhan, N. I., Bradstock, K. F., & Bendall, L. J. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06667.x · Cited by 166
“Perhaps the best evidence for the involvement of Wnt signalling in the aetiology of leukaemia comes from studies where the activation of Wnt signalling was observed during blast crisis in chronic myeloid leukaemia (Jamieson et al, 2004).”
BackgroundRecent advances in acute myeloid leukemia stem cell biology
Horton, S. J., & Huntly, B. J. P. (2012) · Haematologica · doi:10.3324/haematol.2011.054734 · Cited by 179
Direct targeting of β ‐catenin in the Wnt signaling pathway: Current progress and perspectives
Wang, Z., Li, Z., & Ji, H. (2021) · Medicinal Research Reviews · doi:10.1002/med.21787 · Cited by 162
“Enforced expression of Axin suppressed proliferation and self‐renewal capacity of chronic myelogenous leukemia cells that bear activated β‐catenin.(36) Dicer‐substrate small interfering RNAs‐mediated β‐catenin knockdown reduces liver tumor burden in vivo.”
BackgroundPunish the parent not the progeny
Elrick, L. J., Jørgensen, H. G., Mountford, J. C., & Holyoake, T. L. (2004) · Blood · doi:10.1182/blood-2004-08-3373 · Cited by 148
Wang, Y., Cai, D., Brendel, C., Barett, C., Erben, P., Manley, P. W., Hochhaus, A., Neubauer, A., & Burchert, A. (2007) · Blood · doi:10.1182/blood-2006-08-040022 · Cited by 143
O’Flaherty, J. D., Barr, M. P., Fennell, D. A., Richard, D. J., Reynolds, J. V., O’Leary, J. J., & O'Byrne, K. J. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826bfbc6 · Cited by 150
Corces-Zimmerman, M. R., & Majeti, R. (2014) · Leukemia · doi:10.1038/leu.2014.211 · Cited by 141
Curtis, S. J., Sinkevicius, K. W., Li, D., Lau, A. N., Roach, R. R., Zamponi, R., Woolfenden, A. E., Kirsch, D. G., Wong, K.-K., & Kim, C. F. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.05.021 · Cited by 140
“For example, cells with a granulocyte-macrophage progenitor phenotype are the candidate tumor-propagating cells in chronic myelogenous leukemia (Jamieson et al., 2004), whereas in acute myelogenous leukemia, the tumor-propagating cells more closely resemble hematopoietic stem cells or multipotent…”
Which Are the Cells of Origin in Merkel Cell Carcinoma?
Tilling, T., & Moll, I. (2012) · Journal of Skin Cancer · doi:10.1155/2012/680410 · Cited by 141
Right on target: eradicating leukemic stem cells
Krause, D. S., & Etten, R. A. V. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.09.003 · Cited by 164
“Leukemic GMP from CML blast-crisis patientsalsoexhibitedself-renewalcapacity(inareplating assay) that was reduced by enforced expression of axin, an inhibitor of b-catenin signaling [ 32 ].”
BackgroundMethodInfluentialChronic Myeloid Leukemia Stem Cells
Kavalerchik, E., Goff, D., & Jamieson, C. H. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5745 · Cited by 138
“Aberrant Self-Renewal Analysis of CML blast crisis cells showed enhanced canonical Wnt signaling activation through enhanced nuclear localization of the activated b-catenin.(3) Activation of the Wnt signaling in GMP endowed these cells with aberrant self-renewal capacity, normally a property of hematopoietic stem cell…”
BackgroundInfluentialChronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Shah, N. P., Bhatia, R., Altman, J. K., Amaya, M. L., Begna, K. H., Berman, E., Chan, O., Clements, J., Collins, R. H., Curtin, P. T., et al. (2024) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2024.0007 · Cited by 195
Cancer stem cells and their niche
Iwasaki, H., & Suda, T. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01177.x · Cited by 155
Therapeutic Implications of the Cancer Stem Cell Hypothesis
Diehn, M., Cho, R. W., & Clarke, M. F. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.11.002 · Cited by 139
Carlotti, E., Wrench, D., Matthews, J., Iqbal, S., Davies, A. J., Norton, A. J., Hart, J., Lai, R. L., Montoto, S., Gribben, J. G., et al. (2009) · Blood · doi:10.1182/blood-2008-08-174839 · Cited by 139
Targeting hedgehog in hematologic malignancy
Irvine, D. A., & Copland, M. (2012) · Blood · doi:10.1182/blood-2011-10-383752 · Cited by 155
Li, Z., Tognon, C. E., Godinho, F. J., Yasaitis, L. C., Hock, H. R., Herschkowitz, J. I., Lannon, C. L., Cho, E., Kim, S., Bronson, R. T., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.012 · Cited by 143
“In fact, evidence in both patients and mouse models favors a progenitor cell origin for many leukemias (e.g., see Jamieson et al., 2004; Krivtsov et al., 2006).”
BackgroundEstablishment of a Normal Hematopoietic and Leukemia Stem Cell Hierarchy
Chao, M. P., Seita, J., & Weissman, I. L. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.031 · Cited by 138
Breast cancer stem cells: An overview
Ponti, D., Zaffaroni, N., Capelli, C., & Daidone, M. G. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.031 · Cited by 139
Instability of BCR-ABL Gene in Primary and Cultured Chronic Myeloid Leukemia Stem Cells
Jiang, X., Saw, K. M., Eaves, A., & Eaves, C. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk150 · Cited by 137
Stem cells in the etiology and treatment of cancer
Zhang, M., & Rosen, J. M. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.008 · Cited by 143
Selective Inhibition of JAK2-Driven Erythroid Differentiation of Polycythemia Vera Progenitors
Geron, I., Abrahamsson, A. E., Barroga, C. F., Kavalerchik, E., Gotlib, J. R., Hood, J. D., Durocher, J. A., Mak, C. C., Noronha, G., Söll, R., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.017 · Cited by 144
Tumor Dormancy and Cancer Stem Cells: Two Sides of the Same Coin?
Kleffel, S., & Schatton, T. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-1445-2_8 · Cited by 159
“While some experimental tumor model systems have indeed identi fi ed adult tissue stem cells as the source of malignant transformation [ 106, 107 ] , other models have indicated that progenitor or transient amplifying (TA) cells [ 108, 109 ] and perhaps even terminally differentiated cells [ 110 ] could acquire CSC-li…”
ResultWnt Signaling in Normal and Malignant Hematopoiesis
Lento, W. E., Congdon, K. L., Voermans, C., Kritzik, M. R., & Reya, T. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008011 · Cited by 148
CXCR4 Expression in Prostate Cancer Progenitor Cells
Dubrovska, A., Elliott, J., Salamone, R. J., Телегеев, Г. Д., Stakhovskyi, A. E., Schepotin, I. B., Yan, F., Wang, Y., Bouchez, L. C., Kularatne, S. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031226 · Cited by 134
Sànchez‐Tilló, E., Fanlo, L., Siles, L., Montes‐Moreno, S., Moros, A., Chiva‐Blanch, G., Estruch, R., Martínez, A., Colomer, D., Győrffy, B., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.123 · Cited by 139
Donor cell leukemia: insight into cancer stem cells and the stem cell niche
Flynn, C. M., & Kaufman, D. S. (2006) · Blood · doi:10.1182/blood-2006-07-021980 · Cited by 143
Scholl, C., Bansal, D., Döhner, K., Eiwen, K., Huntly, B. J. P., Lee, B. H., Rücker, F. G., Schlenk, R. F., Bullinger, L., Döhner, H., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30182 · Cited by 166
A NEUROSURGEON'S GUIDE TO STEM CELLS, CANCER STEM CELLS, AND BRAIN TUMOR STEM CELLS
Cheshier, S. H., Kalani, M. Y. S., Lim, M. K., Ailles, L., Huhn, S. L., & Weissman, I. L. (2009) · Neurosurgery · doi:10.1227/01.neu.0000349921.14519.2a · Cited by 140
de Toni, F., Racaud‐Sultan, C., Chicanne, G., Mas, V. M., Cariven, C., Briand‐Mésange, F., Salles, J., Demur, C., Allouche, M., Payrastre, B., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209346 · Cited by 134
“Recent studies from Weissman’s group have demonstrated that the morphogen Wnt-dependent signaling is involved in self-renewal and survival of hematopoietic progenitors (Reya et al., 2003), as well as in leukemic potential of leukemic progenitors (Jamieson et al., 2004).”
BackgroundInsco, M. L., Leon, A., Tam, C., Mckearin, D., & Fuller, M. (2009) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0912454106 · Cited by 131
“Indeed, recent evidence points toward cancer initiating events occurring in TA cells in leukemia (2, 3).”
BackgroundStem cells and cancer: an intimate relationship
Burkert, J., Wright, N., & Alison, M. R. (2006) · The Journal of Pathology · doi:10.1002/path.2016 · Cited by 158
“The stem cell profile may also change during the course of a disease; in patients with CML in blast crisis, granulocyte–monocyte progenitors can become self-renewing CSCs, a change associated with Wnt pathway activation [38].”
BackgroundRegulation of c-Myc Ubiquitination Controls Chronic Myelogenous Leukemia Initiation and Progression
Reavie, L., Buckley, S. M., Loizou, E., Takeishi, S., Aranda-Orgilles, B., Ndiaye-Lobry, D., Abdel-Wahab, O., Ibrahim, S., Nakayama, K. I., & Aifantis, I. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.025 · Cited by 131
“Using similar assays, putative LIC populations were also identified in patients diagnosed with CP and BC CML (Jamieson et al., 2004; Sirard et al., 1996; Wang et al., 1998).”
Controversies in Cancer Stem Cells: Targeting Embryonic Signaling Pathways
Takebe, N., & Ivy, S. P. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2934 · Cited by 140
“The Wnt/β-catenin pathway was found to be important in CML granulocyte-macrophage progenitor cells to maintain CSCs (20).”
BackgroundTrastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype
Jiang, J., Zhang, Y., Chuai, S., Wang, Z., Zheng, D., Xu, F., Zhang, Y., Li, C., Liang, Y., & Chen, Z. (2011) · Oncogene · doi:10.1038/onc.2011.282 · Cited by 136
The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications
Medyouf, H. (2017) · Blood · doi:10.1182/blood-2016-11-696070 · Cited by 129
Stem cells in cancer initiation and progression
Bajaj, J., Diaz, E., & Reya, T. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201911053 · Cited by 145
McWeeney, S. K., Pemberton, L. C., Loriaux, M., Vartanian, K. A., Willis, S. G., Yochum, G. S., Wilmot, B., Turpaz, Y., Pillai, R., Druker, B. J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-210732 · Cited by 128
Cancer induction by restriction of oncogene expression to the stem cell compartment
Pérez-Caro, M., Cobaleda, C., González‐Herrero, I., Vicente‐Dueñas, C., Bermejo‐Rodríguez, C., Sánchez‐Beato, M., Órfão, A., Pintado, B., Flores, T., Sánchez‐Martín, M., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.253 · Cited by 128
“However, the percentage of Sca1þLin cells in BM did not increase (data not shown), similarly as it happens in human CML (Jamieson et al, 2004).”
BackgroundGenomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells
Bolton-Gillespie, E., Schemionek, M., Klein, H.-U., Flis, S., Hoser, G., Lange, T., Nieborowska-Skorska, M., Maier, J., Kerstiens, L., Koptyra, M., et al. (2013) · Blood · doi:10.1182/blood-2012-11-466938 · Cited by 128
Molecular Signatures of Quiescent, Mobilized and Leukemia-Initiating Hematopoietic Stem Cells
Forsberg, E. C., Passegué, E., Prohaska, S. S., Wagers, A. J., Koeva, M., Stuart, J. M., & Weissman, I. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008785 · Cited by 127
“or from transformed progenitor cells that have re-acquired the stem cell property of self-renewal”
BackgroundSelf-citationCancer stem cell: Fundamental experimental pathological concepts and updates
Islam, F., Qiao, B., Smith, R. A., Gopalan, V., & Lam, A. K.-Y. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.02.002 · Cited by 145
“On the other hand, studies have found that progenitor cells of CSCs can reacquire the self-renewal capacity through further genetic mutations and epigenetic modifications (Cozzio et al., 2003; Jamieson et al., 2004; Krivtsov et al., 2006).”
BackgroundSecreted frizzled related proteins: Implications in cancers
Surana, R., Sikka, S., Cai, W., Shin, E. M., Warrier, S. R., Tan, H. J. G., Arfuso, F., Fox, S. A., Dharmarajan, A., & Kumar, A. P. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.11.004 · Cited by 139
“Chronic myelogenous leukaemia results from a Bcr-Abl translocation that originates in human stem cells (HSCs) [135] and is dependent on Wnt signalling for growth and renewal [99].”
BackgroundYadav, A. K., & Desai, N. S. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09887-2 · Cited by 133
“the leukemia potential of granulocyte-macrophage progenitors are enhanced due to the accumulation of ß-catenin in the nucleus of these cells[87].”
BackgroundIn vitro generation of human cells with cancer stem cell properties
Scaffidi, P., & Misteli, T. (2011) · Nature Cell Biology · doi:10.1038/ncb2308 · Cited by 134
Wang, Y., Zhang, X., Shao, J., Liu, H., Liu, X., & Luo, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-03899-z · Cited by 133
Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation
Nemeth, M. J., Kirby, M., & Bodine, D. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604006103 · Cited by 128
Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
Rattan, R., Fehmi, R.-A., & Munkarah, A. R. (2012) · Journal of Oncology · doi:10.1155/2012/928127 · Cited by 134
Age-associated changes in human hematopoietic stem cells
Pang, W. W., Schrier, S. L., & Weissman, I. L. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.10.004 · Cited by 130
Mathematical Models of Cancer Stem Cells
Michor, F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2421 · Cited by 130
Clonal evolution of acute leukemia genomes
Jan, M., & Majeti, R. (2013) · Oncogene · doi:10.1038/onc.2012.48 · Cited by 121
RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML
Crews, L. A., Balaian, L., Delos Santos, N. P., Leu, H. S., Court, A. C., Lazzari, E., Sadarangani, A., Zipeto, M. A., La Clair, J. J., Villa, R., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.08.003 · Cited by 121
“…LSCs have been detected in CD34+CD38 or CD34+CD38+ compartments (Eppert et al., 2011), which are comprised of an expanded granulocyte-macrophage progenitor (GMP) population (Goardon et al., 2011; Jamieson et al., 2004), we analyzed these subpopulations in hematopoietic tissues of treated mice.”
Guo, Z., Dose, M., Kovalovsky, D., Chang, R., O'Neil, J., Look, A. T., von Boehmer, H., Khazaie, K., & Gounari, F. (2007) · Blood · doi:10.1182/blood-2006-11-059071 · Cited by 122
RNA editing-dependent epitranscriptome diversity in cancer stem cells
Jiang, Q., Crews, L. A., Holm, F., & Jamieson, C. H. M. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.23 · Cited by 124
IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ
Hsu, L.-C., Enzler, T., Seita, J., Timmer, A. M., Lee, C.-Y., Lai, T.-Y., Yu, G.-Y., Lai, L.-C., Temkin, V., Sinzig, U., et al. (2011) · Nature Immunology · doi:10.1038/ni.1976 · Cited by 120
Noda, T., Nagano, H., Takemasa, I., Yoshioka, S., Murakami, M., Wada, H., Kobayashi, S., Marubashi, S., Takeda, Y., Dono, K., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605064 · Cited by 129
Cancer metabolism: New insights into classic characteristics
Kato, Y., Maeda, T., Suzuki, A., & Baba, Y. (2017) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2017.08.003 · Cited by 135
(A)Symmetric Stem Cell Replication and Cancer
Dingli, D., Traulsen, A., & Michor, F. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030053 · Cited by 126
“]. At present, it is not clear whether CSCs result from the accumulation of mutations in normal SCs or whether more committed cells acquire SC-like properties as a result of mutations. There is data to support both possibilities at least for some neoplasms, and these hypotheses are not mutually exclusive [”
BackgroundApplying the discovery of the Philadelphia chromosome
Sherbenou, D. W., & Druker, B. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31988 · Cited by 119
Insights into the stem cells of chronic myeloid leukemia
Sloma, I., Jiang, X., Eaves, A., & Eaves, C. J. (2010) · Leukemia · doi:10.1038/leu.2010.159 · Cited by 128
Mammary Development and Breast Cancer: A Wnt Perspective
Yu, Q. C., Verheyen, E. M., & Zeng, Y. A. (2016) · Cancers · doi:10.3390/cancers8070065 · Cited by 126
Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling
Shah, K., & Kazi, J. U. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858782 · Cited by 135
Steidl, U., Steidl, C., Ebralidze, A., Chapuy, B., Han, H.-J., Will, B., Rosenbauer, F., Becker, A., Wagner, K., Koschmieder, S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30525 · Cited by 114
Ouyang, G., Wang, Z., Fang, X., Liu, J., & Yang, C. J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0338-2 · Cited by 126
“In patients with a CML blast crisis, a b-catenin mutation may confer selfrenewal properties on granulocyte-macrophage progenitors [51].”
BackgroundLau, C. K., Yang, Z. F., Ho, D. W., Ng, M. N., Yeoh, G. C. T., Poon, R. T. P., & Fan, S. T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2127 · Cited by 113
“This hypothesis posits that cancer stem cells, which represent a reservoir of self-sustaining cells with the capacity for self-renewal and tumor propagation, arise from mutated normal stem cells or progenitor cells (15, 16).”
BackgroundColuccia, A. M. L., Benati, D., Dekhil, H., De Filippo, A., Lan, C., & Gambacorti-Passerini, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2057 · Cited by 113
“Because colon cancer is defective in the mechanisms that promote serine/threonine phosphorylation of h-catenin, it is difficult to assess the relevance or dominant effect of h-catenin tyrosine phosphorylation on its protein turnover, full transcriptional activation, or other post-translational modifications (41); diff…”
BackgroundThe emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia
Mikesch, J.-H., Steffen, B., Berdel, W. E., Serve, H. L., & Müller‐Tidow, C. (2007) · Leukemia · doi:10.1038/sj.leu.2404732 · Cited by 128
Goldman, J. M., & Gordon, M. Y. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500407996 · Cited by 120
“For example, the notion that the quiescent population does not rely on Bcr-Abl expression for survival would explain their lack of sensitivity to TK inhibitors, whereas the reduction by imatinib of the total number of unmutated uncommitted LSCs in cycle and also of the number of committed progenitor cells, of which ei…”
BackgroundLeukemia stem cells: the root of chronic myeloid leukemia
Zhou, H., & Xu, R. (2015) · Protein & Cell · doi:10.1007/s13238-015-0143-7 · Cited by 121
“…tyrosine kinase-directed phosphorylation and mislocalization of cell cycle proteins have been implicated in deregulation of the cell cycle in Bcr-Abl expressing cells, which means that CML quiescent LSCs are TKI resistant and represent a Bcr-Abl kinase-independent disease reservoir (Cramer et…”
BackgroundInfluentialPrecancerous Stem Cells Have the Potential for both Benign and Malignant Differentiation
Chen, L., Shen, R., Ye, Y., Pu, X.-A., Liu, X., Duan, W., Wen, J., Zimmerer, J., Wang, Y., Liu, Y., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000293 · Cited by 110
“the properties of stem cells [11].”
Schürch, C. M., Riether, C., Matter, M. S., Tzankov, A., & Ochsenbein, A. F. (2012) · Journal of Clinical Investigation · doi:10.1172/jci45977 · Cited by 117
CREB is a critical regulator of normal hematopoiesis and leukemogenesis
Cheng, J. C., Kinjo, K., Judelson, D. R., Chang, J. C.-C., Wu, W. S., Schmid, I., Shankar, D. B., Kasahara, N., Stripecke, R., Bhatia, R., et al. (2007) · Blood · doi:10.1182/blood-2007-04-083600 · Cited by 121
Sgroi, D. C. (2009) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092306 · Cited by 149
“The cellular origin of breast cancer is the same as that of tissue stem cells or progenitor cells, and akin to what has been observed in human hematological malignancies (11, 12), genetic transforming events occurring at different development points in the breast stem cell continuum account for breast cancer phenotypi…”
BackgroundRizo, A., Vellenga, E., de Haan, G., & Schuringa, J. J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl175 · Cited by 132
“WNT-induced b-catenin signaling has been implicated in the maintenance and expansion of murine HSCs (20,21), whereas inhibition of b-catenin by overexpression of Axin severely impaired the self-renewal capacity of progenitors in CML (chronic myeloid leukemia) (65).”
Background
Metadata
- Authors
- Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., Sawyers, C. L., & Weissman, I. L.
- Affiliations
- Stanford Medicine (US)
- University of Toronto (CA)
- University of California, Los Angeles (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-08-12
- Volume
- 351
- Issue
- 7
- Pages
- 657-667
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012962381
- Cited by
- 1,485
- References
- 58
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 19 · 2023: 36 · 2022: 27 · 2021: 33 · 2020: 40 · 2019: 37 · 2018: 40 · 2017: 53 · 2016: 80 · 2015: 74 · 2014: 81 · 2013: 95 · 2012: 114
- FWCI
- 55.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23HL04409, K23HL004409)
- National Cancer Institute (2PO1CA49605, CA 86017, CA 55209, R01CA086017, P01CA049605)
- National Institute of Allergy and Infectious Diseases (5 T32 AI07290, T32AI007290)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- chronic myeloid leukemia, blast crisis, leukemia stem cells, CFU-GM, β-catenin signaling, BCR-ABL, self-renewal, Axin, imatinib resistance, hematopoietic stem cells, myeloid progenitor cells
- MeSH terms
- Imatinib Mesylate, Adult, Aged, Antineoplastic Agents, Benzamides, Blast Crisis, Colony-Forming Units Assay, Cytoskeletal Proteins, DNA-Binding Proteins, Female, Granulocytes, Hematopoietic Stem Cells, Humans, Macrophages, Male, Middle Aged, Piperazines, Pyrimidines, RNA, Neoplasm, Transcription Factors, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Trans-Activators, Fusion Proteins, bcr-abl, Microscopy, Confocal, Drug Resistance, Neoplasm, Reverse Transcriptase Polymerase Chain Reaction, beta Catenin, Lymphoid Enhancer-Binding Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.